Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (30075)	4/14/1999 12:39:00 PM
From: Doorman	Read Replies (1) \| Respond to of 122087

<enmd> Thanks Anthony and Mama and those that PM'ed. You guys make me proud to be part of this thread. Anthony - Do you think I have a case for gettng filled 1000 SS @ 34 1/2 based on the two trades at 34 3/4? Mama points out: <33 7/16 x 34 at 11:04:01 as the high inside spread for ENMD today. It looks like higher trades printed, but it was likely panic buying over the offer through ECNs. >> Really appreciate your help.

To: Anthony@Pacific who wrote (30075)	4/15/1999 12:47:00 AM
From: M. LaMancha	Respond to of 122087

ENMD -- closure -- anyone short on ENMD, please be careful. I covered a painful short today after reading preclinical (yeah, really) results. It stuck me because they replicated earlier results with the process that will deliver clinical dose quantities. Up until now, I believed they were whistling in the dark, with Bristol Myers backing away because of manufacturing concerns. Now I think they might actually be able to do what they say, and if they can go to clinicals, anybody short is in trouble. Hopefully I am the last of our group to be short this stock. Good luck all.